J3O

Fenofibrate

Created:	2023-08-07
Last modified:	2024-11-11

Find Related PDB Entry
1 entries where J3O is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	46
Chiral Atom Count	0
Bond Count	47
Aromatic Bond Count	12

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Fenofibrate
Systematic Name (OpenEye OEToolkits)	propan-2-yl 2-[4-(4-chlorophenyl)carbonylphenoxy]-2-methyl-propanoate
Formula	C₂₀ H₂₁ Cl O₄
Molecular Weight	360.831
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2
SMILES	OpenEye OEToolkits	2.0.7	CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(cc2)Cl
Canonical SMILES	CACTVS	3.385	CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(cc2)Cl
InChI	InChI	1.06	InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3
InChIKey	InChI	1.06	YMTINGFKWWXKFG-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB01039
Name	Fenofibrate
Groups	approved
Description	Fenofibrate is a fibric acid derivative like [clofibrate] and [gemfibrozil].[A185954] Fenofibrate is used to treat primary hypercholesterolemia, mixed dyslipidemia, severe hypertriglyceridemia.[L8588,L8591] Fenofibrate was granted FDA approval on 31 December 1993.[L8585]
Synonyms	Fenofibrate Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate 2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester Procetofen Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate Fenofibratum Finofibrate FNF Fenofibrato
Brand Names	Pro-feno-super - 100 Lofibra Aa-feno-super Mint-fenofibrate E Fenofibrate film coated Lipidil Ez Triglide Sandoz Fenofibrate S PHL-fenofibrate Micro Ntp-fenofibrate-S Feno-micro-200 PMS-fenofibrate Micro Fenofibrate Micro Antara Ava-fenofibrate Micro Dom-fenofibrate Supra Sandoz Fenofibrate E Mylan-fenofibrate Micro Novo-fenofibrate Micronized Teva-fenofibrate-S Dom-fenofibrate Micro Tricor Pro-feno-super - 160 Ran-fenofibrate S Taro-fenofibrate E Fenoglide Ratio-fenofibrate Mc Novo-fenofibrate Fenofibrate Aa-feno-micro Lipidil Cap 100mg Lipidil Supra 100 mg Pravafenix Riva-fenofibrate Micro PHL-fenofibrate Supra Fenofibrate-S Lipofen Lipidil Micro PMS-fenofibrate Cholib Lipidil Supra PMS-fenofibrate Supra Q-fenofibrate Micro Lipidil Micro - Cap 67mg Nu-feno-micro Fenomax
Indication	Fenofibrate is indicated as adjunctive therapy to diet:[L51464] - To reduce triglyceride (TG) levels in adults with severe hypertriglyceridemia (TG greater than or equal to 500 mg/dL) - To reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia when the use of recommended LDL-C lowering therapy is not possible
Categories	Acids, Acyclic Agents Causing Muscle Toxicity Benzene Derivatives Benzophenones BSEP/ABCB11 Substrates Butyrates Cytochrome P-450 CYP2A6 Inhibitors Cytochrome P-450 CYP2A6 Inhibitors (weak) Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 CYP2C19 Inhibitors (weak) Cytochrome P-450 CYP2C8 Inhibitors Cytochrome P-450 CYP2C8 Inhibitors (weak) Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates (strength unknown) Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Ethers Fatty Acids Fatty Acids, Volatile Fibric Acid Derivatives Fibric Acids Hypolipidemic Agents Hypolipidemic Agents Indicated for Hyperlipidemia Isobutyrates Ketones Lipid Modifying Agents Lipid Modifying Agents, Plain Lipid Regulating Agents Lipids Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia Noxae P-glycoprotein inhibitors Peroxisome Proliferator Receptor alpha Agonist Peroxisome Proliferator-activated Receptor alpha Agonists Phenols Phenyl Ethers Toxic Actions UGT1A9 Substrates
ATC-Code	C10BA03 C10BA12 C10AB05 C10BA09 C10BA04
CAS number	49562-28-9

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Peroxisome proliferator-activated receptor alpha	MVDTESPLCPLSPLEAGDLESPLSEEFLQEMGNIQEISQSIGEDSSGSFG...	unknown	agonist
Nuclear receptor subfamily 1 group I member 2	MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATG...	unknown	partial agonist
Matrix metalloproteinase-25	MRLRLRLLALLLLLLAPPARAPKPSAQDVSLGVDWLTRYGYLPPPHPAQA...	unknown	inhibitor
UDP-glucuronosyltransferase 1A9	MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLIL...	unknown	substrate
Liver carboxylesterase 1	MWLRAFILATLSASAAWGHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAIF...	unknown	substrate
Carbonyl reductase [NADPH] 1	MSSGIHVALVTGGNKGIGLAIVRDLCRLFSGDVVLTARDVTRGQAAVQQL...	unknown	substrate
Cytochrome P450 2C8	MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...	unknown	inhibitor
Cytochrome P450 2C19	MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...	unknown	inhibitor
Cytochrome P450 2A6	MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLN...	unknown	inhibitor
Aldo-keto reductase family 1 member C1	MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEATKLAIEAGFRHID...	unknown	substrate
Aldo-keto reductase family 1 member C2	MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHID...	unknown	substrate
Aldo-keto reductase family 1 member C3	MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHID...	unknown	substrate
Aldo-keto reductase family 1 member B1	MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQ...	unknown	substrate
Cytochrome P450 2C9	MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...	unknown	inhibitor
Albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	binder
Bile salt export pump	MSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQL...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682